The SUBITO-DE study: Sexual dysfunction in newly diagnosed Type 2 diabetesmale patients

Journal of Endocrinological Investigation

Volumn 36, Issue 10, 2013, Pages 864-868

  Corona, G ^a,f   Giorda, C B ^b,f   Cucinotta, D ^c,f   Guida, P ^d   Nada, E ^e,f   Aglialoro, A ^f   Albanese, V ^f   Albano, S ^f   Antonangelo, C ^f   Baccetti, F ^f   Bulzomi', R ^f   Calatola, P ^f   Capano, F ^f   Clemente, G ^f   Corigliano, G ^f   De Fazio, C ^f   De Francesco, C ^f   De Joannon, U ^f   Del Buono, A ^f   Fontana, L ^f   Fornengo, R ^f   Fraticelli, E ^f   Gaviglio, D ^f   Gentile, S ^f   Giorgianni, L ^f   Guarino, G ^f   Iannarelli, R ^f   Improta, L ^f   Improta, M ^f   Leotta, S ^f   Magro, G ^f   Maiani, L ^f   Mingardi, R ^f   Morviducci, L ^f   Nosso, G ^f   Nuzzi, A ^f   Ocelli, C ^f   Paciotti, V ^f   Pata, P ^f   Rampini, P A ^f   Rovere, M ^f   Sabbatini, A ^f   Sciarrafia, M ^f   Sciarretta, F ^f   Sforza, A ^f   Starnone, V ^f   Testori, G ^f   Trevisan, F ^f   Turco, S ^f   Viviani, G ^f   Zavaroni, D ^f   more..

^a BELLARIA HOSPITAL   (Italy)

^b ASL Torino 5   (Italy)

^c Policlinico di Messina   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e Chaira Medica Association   (Italy)

^f NONE

Author keywords

Depression; Erectile dysfunction; Hypogonadism; SUBITO DE study; Type 2 diabetes

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EZETIMIBE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INCRETIN; INSULIN; NITRATE; PROSTAGLANDIN E1; SARTAN DERIVATIVE; SILDENAFIL; TADALAFIL; TESTOSTERONE; VARDENAFIL;

ADULT; AGED; ARTICLE; COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG WITHDRAWAL; DYSLIPIDEMIA; ERECTILE DYSFUNCTION; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOGONADISM; INTERVIEW; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY;

COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; DIABETES MELLITUS, TYPE 2; ERECTILE DYSFUNCTION; FOLLOW-UP STUDIES; HUMANS; HYPOGONADISM; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TESTOSTERONE;

EID: 84891718176     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8969     Document Type: Article

References (51)

1. Boddi V, Corona G, Fisher AD, et al. "It takes two to tango": The relational domain in a cohort of subjects with erectile dysfunction (ED). J Sex Med 2012, Oct 4 [Epub ahead of print]; doi: 10.1111/j.1743-6109.2012.02948. x.
2. Corona G, Ricca V, Bandini E, et al. SIEDY Scale 3, a new instrument to detect psychological component in subjects with erectile dysfunction. J Sex Med 2012, May 17 [Epub ahead of print]; doi:10.1111/j.1743-6109.2012.02762.x.
3. Corona G, Mannucci E, Petrone L, et al. Psycho-biological correlates of free-floating anxiety symptoms in male patients with sexual dysfunctions. J Androl 2006, 27: 86-93.
4. Corona G, Monami M, Boddi V, et al. Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction. J Sex Med 2010, 7: 1918-27.
5. Corona G, Petrone L, Mannucci E, et al. Assessment of the relational factor in male patients consulting for sexual dysfunction: the concept of couple sexual dysfunction. J Androl 2006, 27: 795-801.
6. Corona G, Mannucci E, Forti G, Maggi M. Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? Int J Androl 2009, 32: 431-41.
7. Lewis RW, Fugl-Meyer KS, Corona G, et al. Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med 2010, 7: 1598-607.
8. Traish AM, Guay A, Feeley R, Saad F. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl 2009, 30: 10-22.
9. Fedele D, Bortolotti A, Coscelli C, et al. Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici. Int J Epidemiol 2000, 29: 524-31.
10. Fedele D, Coscelli C, Santeusanio F, et al. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care 1998, 21: 1973-7.
11. Whitehead ED, Klyde BJ. Diabetes-related impotence in the elderly. Clin Geriatric Med 1990, 6: 771-95.
12. Siu SC, Lo SK, Wong KW, Ip KM, Wong YS. Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients. Diabet Med 2001, 18: 732-8.
13. El-Sakka AI, Tayeb KA. Erectile dysfunction risk factors in noninsulin dependent diabetic Saudi patients. J Urol 2003, 169: 1043-7.
14. Cho BL, Kim YS, Hong MH, et al. Prevalence and risk factors for erectile dysfunction in primary care: Results of a Korean study. Int J Impot Res 2003, 15: 323-8.
15. Giuliano FA, Leriche A, Jaudinot EO, de Gendre AS. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology 2004, 64: 1196-201.
16. Rosen RC, Wing RR, Schneider S, et al. Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD Trial. J Sex Med 2009, 6: 1414-22.
17. Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med 2009, 6: 1232-47.
18. De Barardis G, Franciosi M. Belfiglio M, et al. Erectile dysfunction and quality of life in type 2 diabetic patients: A serious problem too often overlooked. Diabetes Care 2002, 25: 284-91.
19. Penson DF, Latini DM, Lubeck DP, Wallace KL, Henning JM, Lue TF. Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Diabetes Care 2003, 26: 1093-9.
20. Fedele D, Coscelli C, Cucinotta D, et al. Diabete Study Group. Incidence of erectile dysfunction in Italian men with diabetes. J Urol 2001, 166: 1368-71.
21. Derby CA, Araujo AB, Johannes CB, Feldman HA, McKinlay JB. Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts Male Aging Study. Int J Impot Res 2000, 12: 197-204.
22. Gazzaruso C, Giordanetti S, De Amici E, et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004, 110: 22-6.
23. Gazzaruso C, Solerte SB, Pujia A, et al. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol 2008, 51: 2040-4.
24. Ma R, SoW, Yang X, et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol 2008, 51: 2045-50.
25. Corona G, Fagioli G, Mannucci E, et al. Penile doppler ultrasound in patients with erectile dysfunction (ED): role of peak systolic velocity measured in the flaccid state in predicting arteriogenic ED and silent coronary artery disease. J Sex Med 2008, 5: 2623-34.
26. Corona G, Rastrelli G, Balercia G, et al. Hormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal study. J Sex Med 2012, 9: 1669-80.
27. Traish AM, Saad F, Guay A. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl 2009, 30: 23-32.
28. Corona G, Monami M, Boddi V, et al. Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction. J Sex Med 2010, 7: 1557-64.
29. Corona G, Rastrelli G, Monami M, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol 2011, 165: 687-701.
30. Bruno G, De Micheli A, Frontoni S, Monge L, on behalf of SID-AMD Working Group on the Standards of Care for Diabetes. Highlights from "Italian Standards of Care for Diabetes Mellitus 2009-2010". Nutr Metab Cardiovasc Dis 2011, 21: 302-14.
31. Rosen RC, Riley A, Wagner G, Osterloth IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997, 49: 822-30.
32. Radloff LS. The CES-S Scale: a self report depression scale for research in the general population. Appl Psychol Meas 1977, 1: 385.
33. Corona G, Mannucci E, Petrone L, et al. ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction. J Sex Med 2006, 3: 706-15.
34. Corona G, Rastrelli G, Vignozzi L, Mannucci E, Maggi M. How to recognize late-onset hypogonadism in men with sexual dysfunction. Asian J Androl 2012, 14: 251-9.
35. Wang C, Nieschlag E, Swerdloff R, et al International Society of Andrology; International Society for the Study of Aging Male; European Association of Urology; European Academy of Andrology; American Society of Andrology. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol 2009, 55: 121-30.
36. Hatzimouratidis K, Amar E, Eardley I, et al European Association of Urology. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010, 57: 804-14.
37. Buvat J, Maggi M, Guay A, Torres LO. Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. J Sex Med 2012, Sep 12 [Epub ahead of print]; doi: 10.1111/j.1743-6109.2012. 02783.x.
38. Wu FC, Tajar A, Beynon JM, et al EMAS Group. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010, 363: 123-35.
39. Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc 2012, 87: 766-78.
40. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27: 1047-53.
41. von Eckardstein A, Schulte H, Assmann G. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster. J Clin Endocrinol Metab 2000, 85: 3101-8.
42. Gatling W, Guzder RN, Turnbull JC, Budd S, Mullee MA; Poole Diabetes Study. The Poole Diabetes Study: how many cases of Type 2 diabetes are diagnosed each year during normal health care in a defined community? Diab Res Clin Pract 2001, 53: 107-12.
43. Klotz T, Mathers M, Klotz R, Sommer F. Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra)? Int J Impot Res 2005, 17: 2-4.
44. Hatzimouratidis K, Hatzichristou D. Phosphodiesterase type 5 inhibitors: the day after. Eur Urol 2007, 51: 75-88.
45. Corona G,MonamiM, Rastrelli G, et al. Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int J Androl 2011, 34: 528-40.
46. Corona G, Rastrelli G, Forti G, Maggi M. Update in testosterone therapy for men. J Sex Med 2011, 8: 639-54.
47. Nouwen A, Nefs G, Caramlau I, et al European Depression in Diabetes Research Consortium. Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium. Diabetes Care 2011, 34: 752-62.
48. Nouwen A, Winkley K, Twisk J, et al European Depression in Diabetes (EDID) Research Consortium. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 2010, 53: 2480-6.
49. Shiri R, Koskimäki J, Tammela TL, Häkkinen J, Auvinen A, Hakama M. Bidirectional relationship between depression and erectile dysfunction. J Urol 2007, 177: 669-73.
50. Corona G, Ricca V, Bandini E, et al. Association between psychiatric symptoms and erectile dysfunction. J Sex Med 2008, 5: 458-68.
51. Gartlehner G, Hansen RA, Morgan LC, et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med 155: 772-85, 2011.